Post-IPO Equity Medical Companies

Pulse Biosciences is a medical device company that engages in the research and development, and commercialization of CellFX system.

Thiogenesis Therapeutics is a clinical-stage biotech company that develops thiol-active therapeutics to treat medical diseases.

Picard Medical brings to the table technical and commercial expertise.

Cabaletta Bio has adapted clinically-validated and FDA-approved CAR T cell technology to target B cell-mediated autoimmune diseases.

Valneva focuses on the development and commercialization of prophylactic vaccines for infectious diseases.

Oruka Therapeutics is advancing innovative biologics to redefine patient care standards in chronic skin diseases.

Climb Bio occurs when the immune system mistakenly attacks the body's tissues and can result in permanent organ damage or even death.

Paradigm is a global biopharmaceutical company driven to discover to improve patients’ health and quality of life

SenseTime is an AI software company focused on creating a better AI-empowered future through innovation.

Telomir Pharmaceuticals develops a novel treatment that binds critical metals to interrupt enzyme function.

The AlzeCure Foundation is focused on the development of novel diagnostics and therapeutics for PD.

A health sciences company that develops innovative options for preventive and curative therapies .

Hepion Pharmaceuticals is a clinical stage biopharmaceutical company.

Perimeter Medical Imaging is a medical technology company.

National Healthcare Properties is a real estate investment agency that develops a portfolio of medical real estate properties.

Shortwave Life Sciences is a biotech company that develops psychedelics-based medicine.

Onward develops an Implantable Neuro-stimulation System (INS) with real-time motion feedback and uses training tools.

Lunai Bioworks is a biotechnology business committed to developing enhanced allogenic cell and gene therapies.

Revolution Medicines is an innovative and dynamic organization of expert biologists, chemists, pharmacologists, clinical scientists.

HeartBeam is a cardiac technology company that has created the first and only 3D-vector electrocardiogram (VECG) platform.

BiBBInstruments has develops an instrument that allows quick and easy sampling of suspected cancer tumors by drilling into the tissue.

A GI-focused digital health company offering an evidence-based, clinically validated condition management program

Hoth Therapeutics is a clinical-stage biopharmaceutical company focusing on developing new therapies for dermatological disorders.

Cadrenal Therapeutics develops a late-stage novel therapy for patients with end-stage renal disease and atrial fibrillation.

NewcelX is a clinical-stage drug development company focusing on neurobehavioral and neurocognitive disorders and their pharmacognosia.